The impact of FDG-PET/CT on the management of head and neck tumours: The radiotherapist's perspective

Oral Oncology

Volumn 44, Issue 5, 2008, Pages 504-508

  Dietl, Barbara ^a   Marienhagen, Jörg ^a   Kühnel, Thomas ^a   Schreyer, Andreas ^a   Kölbl, Oliver ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Diagnostic impact; FDG PET CT; Head and neck tumours; Radiotherapy; Therapeutic impact

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HEAD AND NECK CANCER; HISTOLOGY; HUMAN; MALE; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; DATA INTERPRETATION, STATISTICAL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MEDICAL STAFF, HOSPITAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 42949175856     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2007.06.014     Document Type: Article

References (30)

1. Kapoor V., Fukui M.B., and McCook B.M. Role of 18FFDG PET/CT in the treatment of head and neck cancers: principles, technique, normal distribution, and initial staging. AJR Am J Roentgenol 184 2 (2005) 579-587
2. Reske S.N., and Kotzerke J. FDG-PET for clinical use. Eur J Nucl Med 28 11 (2001) 1707-1723
3. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistic 2007. CA Cancer J Clin 57 1 (2007) 43-66
4. Hao D., Ritter M.A., Oliver T., and Browman G.P. Platinum-based concurrent chemoradiotherapy for tumors of the head and neck and the esophagus. Semin Radiat Oncol 16 1 (2006) 10-19
5. Mendenhall W.M., Hinerman R.W., Amdur R.J., Malyapa R.S., Lansford C.D., Werning J.W., et al. Postoperative radiotherapy for squamous cell carcinoma of the head and neck. Clin Med Res 4 3 (2006) 200-208
6. Seiwert T.Y., and Cohen E.E. State-of-the-art management of locally advanced head and neck cancer. Br J Cancer 92 8 (2005) 1341-1348
7. Yuasa K., Kawazu T., Nagata T., Kanda S., Ohishi M., and Shirasuna K. Computed tomography and ultrasonography of metastatic cervical lymph nodes in oral squamous cell carcinoma. Dentomaxillofac Radiol 29 4 (2000) 238-244
8. van den Brekel M.W. Lymph node metastases: CT and MRI. Eur J Radiol 33 3 (2000) 230-238
9. Warburg O. On the origin of cancer cells. Science 123 3191 (1956) 309-314
10. Belkacemi Y., Tsoutsou P., Magne N., Castadot P., and Azria D. Metabolic functional imaging for tumor radiosensitivity monitoring. Crit Rev Oncol Hematol (2007)
11. Strauss L.G. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 23 10 (1996) 1409-1415
12. Berger D.S., and Fletcher G.H. Distant metastases following local control of squamous-cell carcinoma of the nasopharynx, tonsillar fossa, and base of the tongue. Radiology 100 1 (1971) 141-143
13. Jackel M.C., and Rausch H. Distant metastasis of squamous epithelial carcinomas of the upper aerodigestive tract. The effect of clinical tumor parameters and course of illness. HNO 47 1 (1999) 38-44
14. Dietl B., Marienhagen J., Schaefer C., Pohl F., Murthum T., and Kolbl O. Survival with distant metastatic disease in head and neck cancer: a retrospective analysis. HNO (2007)
15. Reiner B., Siegel E., Sawyer R., Brocato R.M., Maroney M., and Hooper F. The impact of routine CT of the chest on the diagnosis and management of newly diagnosed squamous cell carcinoma of the head and neck. AJR Am J Roentgenol 169 3 (1997) 667-671
16. de Bree R., Deurloo E.E., Snow G.B., and Leemans C.R. Screening for distant metastases in patients with head and neck cancer. Laryngoscope 110 3 Pt 1 (2000) 397-401
17. Schwartz D.L., Rajendran J., Yueh B., Coltrera M., Anzai Y., Krohn K., et al. Staging of head and neck squamous cell cancer with extended-field FDG-PET. Arch Otolaryngol Head Neck Surg 129 11 (2003) 1173-1178
18. Calhoun K.H., Fulmer P., Weiss R., and Hokanson J.A. Distant metastases from head and neck squamous cell carcinomas. Laryngoscope 104 10 (1994) 1199-1205
19. Troell R.J., and Terris D.J. Detection of metastases from head and neck cancers. Laryngoscope 105 3 Pt 1 (1995) 247-250
20. Haughey B.H., Gates G.A., Arfken C.L., and Harvey J. Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 101 2 Pt 1 (1992) 105-112
21. Leon X., Quer M., Diez S., Orus C., Lopez-Pousa A., and Burgues J. Second neoplasm in patients with head and neck cancer. Head Neck 21 3 (1999) 204-210
22. Di Martino E., Sellhaus B., Hausmann R., Minkenberg R., Lohmann M., and Esthofen M.W. Survival in second primary malignancies of patients with head and neck cancer. J Laryngol Otol 116 10 (2002) 831-838
23. Erkal H.S., Mendenhall W.M., Amdur R.J., Villaret D.B., and Stringer S.P. Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites. J Clin Oncol 19 5 (2001) 1358-1362
24. Olsen K.D., Caruso M., Foote R.L., Stanley R.J., Lewis J.E., Buskirk S.J., et al. Primary head and neck cancer. Histopathologic predictors of recurrence after neck dissection in patients with lymph node involvement. Arch Otolaryngol Head Neck Surg 120 12 (1994) 1370-1374
25. Bussels B., Hermans R., Reijnders A., Dirix P., Nuyts S., and Van den Bogaert W. Retropharyngeal nodes in squamous cell carcinoma of oropharynx: incidence, localization, and implications for target volume. Int J Radiat Oncol Biol Phys 65 3 (2006) 733-738
26. Alvi A., and Johnson J.T. Development of distant metastasis after treatment of advanced-stage head and neck cancer. Head Neck 19 6 (1997) 500-505
27. Snow G.B., Patel P., Leemans C.R., and Tiwari R. Management of cervical lymph nodes in patients with head and neck cancer. Eur Arch Otorhinolaryngol 249 4 (1992) 187-194
28. Castelijns J.A., and van den Brekel M.W. Imaging of lymphadenopathy in the neck. Eur Radiol 12 4 (2002) 727-738
29. Gregoire V., Bol A., Geets X., and Lee J. Is PET-based treatment planning the new standard in modern radiotherapy? The head and neck paradigm. Semin Radiat Oncol 16 4 (2006) 232-238
30. Wong S.J., Machtay M., and Li Y. Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?. J Clin Oncol 24 17 (2006) 2653-2658